Results 251 to 260 of about 94,390 (312)

Real-world analysis of pharmacological treatments to prevent relapse after electroconvulsive therapy for major depressive disorder: A nationwide cohort study. [PDF]

Transl Psychiatry
Kronsell A, Nordenskjöld A, Bodén R, Mittendorfer-Rutz E, Reutfors J, Rossides M, Tiger M.   +6 more
europepmc   +1 more source

Epidemiology and care management of Paroxysmal Nocturnal Hemoglobinuria (PNH) in a real-world setting in France: Description from the French National Hospitalization Database. [PDF]

PLoS One
Peffault de Latour R, Pibre S, Vercruyssen J, Desjuzeur-Bellais ML, Pau D, Bénard S, Chillotti L, Grandfils N.   +7 more
europepmc   +1 more source

Overstated association between adolescent physical fitness and adulthood depression risk due to familial factors. [PDF]

J Intern Med
Ballin M, Ekblom Ö, Nordström A, Ahlqvist VH, Nordström P.   +4 more
europepmc   +1 more source

Trends in Medication Use Among Young Adults and the Covid-19 Pandemic Effect. [PDF]

Pharmacoepidemiol Drug Saf
Zur M, Tsur AM, Friedensohn L, Matok I.
europepmc   +1 more source

The impact of long-term adherence to guideline-directed medical therapy on outcomes in peripheral artery disease. [PDF]

Vasc Med
Furlan T, Bijec J, Došenović Bonča P, Ograjenšek I, Jug B.   +4 more
europepmc   +1 more source

Slow-Release Oral Morphine vs Methadone for Opioid Use Disorder in the Fentanyl Era.

JAMA Netw Open
Socias ME, Lei J, Zhou V, Anand R, Cui Z, Penta S, Larochelle M, Lodi S, Fairbairn N.   +8 more
europepmc   +1 more source

Factors associated with changes in opioid analgesic prescribing after opioid agonist treatment initiation: A nationwide registry cohort study. [PDF]

Drug Alcohol Depend Rep
Rolova G, Skurtveit S, Bukten A, Odsbu I, Eide D.   +4 more
europepmc   +1 more source

Prior Authorization and Associated Delays and Denials of Branded Medication Dispensation.

JAMA Health Forum
Wang Y, Levy JF, Mattingly TJ, Anderson G.   +3 more
europepmc   +1 more source